Company intelligence / Profile preview

Twist Consulting

South San Francisco, California, United Statestwist-consulting.com ↗

Ownership: Private
Employees: ~950
Development stage: Other

Overview

Twist Bioscience has developed a proprietary silicon-based DNA synthesis technology that enables high-throughput production of synthetic genes, oligo pools, NGS tools, and antibody libraries. Their platforms are used by partners in drug discovery and diagnostics. They have enabled at least one antibody program to enter clinical studies through outlicensing to Revelar Biotherapeutics. They also provide services for biopharma partners across the R&D spectrum.

Modalities: Monoclonal antibodyAntibody-drug conjugateSynthetic gene/DNA products
Industry: Non-Drug Biotech

Partnerships

Invetx (animal health antibodies)Numerous pharma/biotech collaborations via Twist Biopharma Solutions

Beyond the preview

Go deeper on Twist Consulting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Twist Consulting.

Explore the full profile